Personalized medicine with biologics for severe type 2 asthma: current status and future prospects

@inproceedings{Godar2018PersonalizedMW,
  title={Personalized medicine with biologics for severe type 2 asthma: current status and future prospects},
  author={Marie Godar and Christophe Blanchetot and Hans J W de Haard and Bart N Lambrecht and Guy G Brusselle},
  booktitle={mAbs},
  year={2018}
}
Asthma affects more than 300 million people worldwide and poses a large socioeconomic burden, particularly in the 5% to 10% of severe asthmatics. So far, each entry of new biologics in clinical trials has led to high expectations for treating all severe asthma forms, but the outcome has only been successful if the biologic, as add-on treatment, targeted specific patient subgroups. Indeed, we now realize that asthma is a heterogeneous disease with multiple phenotypes, based on distinct… CONTINUE READING
Highlighted Tweets
This paper has been referenced on Twitter 5 times. VIEW TWEETS

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 75 REFERENCES